Abstract
In autoimmune diseases, recognition of self-antigens presented by major histocompatibility complex (MHC) molecules elicits unexpected attack of tissue by autoantibodies and/or autoreactive T cells. Post-translational modification (PTM) may alter the MHC-binding motif or TCR contact residues in a peptide antigen, transforming the tolerance to self to autoreactivity. Mass spectrometry-based immunopeptidomics provides a valuable mechanism for identifying MHC ligands that contain PTMs and can thus provide valuable insights into pathogenesis and therapeutics of autoimmune diseases. A plethora of PTMs have been implicated in this process, and this review highlights their formation and identification.
| Original language | English |
|---|---|
| Article number | 101730 |
| Journal | Seminars in immunology |
| Volume | 66 |
| DOIs | |
| State | Published - Mar 2023 |
Keywords
- Antigen presentation
- Autoimmunity
- ER stress
- Immunopeptidomics
- Neoantigen
- Oxidative stress
- Type 1 diabetes
Fingerprint
Dive into the research topics of 'Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver